NIRAPARIB vs RUCAPARIB CAMSYLATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIRAPARIB vs RUCAPARIB CAMSYLATE: Safety Overview
| Metric | NIRAPARIB | RUCAPARIB CAMSYLATE |
|---|---|---|
| Total FAERS Reports | 21,634 | 8,240 |
| Deaths Reported | 1,370 | 448 |
| Death Rate | 6.3% | 5.4% |
| Hospitalizations | 4,892 | 1,148 |
| Average Patient Age | 65.7 yrs | 65.1 yrs |
| % Female Patients | 98.5% | 95.2% |
| FDA Approval Date | Apr 26, 2023 | Dec 19, 2016 |
| Manufacturer | GlaxoSmithKline LLC | pharmaand GmbH |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |